Submitted by Anonymous (not verified) on 25 April 2025 - 15:00
Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Positive
Source:
Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Positive